We are a dedicated team of scientists, clinicians, and industry and business professionals.
Nicole Bucala, CEO
Nicole graduated with an MBA from Harvard Business School, having previously received an SB from MIT and SM from Georgetown Medical Center. Building on a strong background in operations and policy implementation, she has recruited MIFCOR's scientific and clinical team, led the development of advisory relationships to inform business and clinical development, and steered the team forward from initiation through licensing negotiations and fundraising.
Clay Wiske, CFO
Clay combines experience in management consulting and medical research, in the fields of cardiology, obesity, and diagnostics. He was a co-founder and CFO of FlowLight, a medical device startup that developed novel technology to monitor for post-operative acute limb ischemia. Clay is finishing up his MD at Brown. He received an MBA from Harvard Business School and earned masters and bachelors degrees in nanotechnology and physics from the University of Cambridge, UK, and Columbia University.
Dr. Richard Bucala, Inventor
Currently a Professor of Medicine at Yale University, Rick was the first to functionally clone MIF protein and has studied the MIF/MIF-2 biology for the past few decades. He holds ~40 patents and has a proven track record commercializing his science through out-licensing deals to large pharmaceutical companies and biotech startups. In addition to running a large research lab, Rick is a practicing physician, and board certified in internal medicine and rheumatology.